Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Average Recommendation of "Buy" from ...

Retrieved on: 2020-12-15 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Average Recommendation of "Buy" from .... View article details on hiswai:

Excerpt

It develops CDX-1140, an agonist human <b>monoclonal antibody</b>, which is being studied as a single-agent and in combination with CDX-301 in a Phase ...

Article found on: www.marketbeat.com

View Original Article